linfoma de hodgkin

Hodgkin Lymphoma: Practice Essentials, Background, Pathophysiology

Medscape Reference - 21 Oct 2024
Hodgkin Lymphoma: Practice Essentials, Background, Pathophysiology ...

Hodgkin lymphoma (Hodgkin disease) - Symptoms and causes

Mayo Clinic - 05 Jun 2024
Hodgkin lymphoma (Hodgkin disease) - Symptoms and causes ...

The causality between gut microbiota and non-Hodgkin lymphoma: a two-sample bidirectional Mendelian randomization study

Frontiers - 27 May 2024
The causality between gut microbiota and non-Hodgkin lymphoma: a two-sample bidirectional Mendelian randomization study ...

Non-Hodgkin's lymphoma - Symptoms and causes

Mayo Clinic - 03 May 2024
Non-Hodgkin's lymphoma - Symptoms and causes ...

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

nejm.org - 16 Oct 2024
Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma ...

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

Nature.com - 11 Dec 2023
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling ...

Hodgkin's Lymphoma

Yale Medicine - 25 Sep 2021
Hodgkin's Lymphoma ...

Non-Hodgkin Lymphoma Imaging Spectrum in Children, Adolescents, and Young Adults

RSNA Publications Online - 17 Jun 2022
Non-Hodgkin Lymphoma Imaging Spectrum in Children, Adolescents, and Young Adults ...

Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives | Blood Cancer Journal

Nature.com - 25 Jan 2024
Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives | Blood Cancer Journal ...

Non-Hodgkin lymphoma: Excellent results at the expense of the high toxicity of the treatment

Anales de Pediatría - 04 Jun 2018
Non-Hodgkin lymphoma: Excellent results at the expense of the high toxicity of the treatment ...

Identification of a Torque Teno Mini Virus (TTMV) in Hodgkin’s Lymphoma Patients

Frontiers - 11 Feb 2024
Identification of a Torque Teno Mini Virus (TTMV) in Hodgkin’s Lymphoma Patients ...

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma

nejm.org - 13 Jul 2022
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma ...

Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis | Leukemia

Nature.com - 18 Jan 2024
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis | Leukemia ...

Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma

Frontiers - 26 Jun 2024
Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma ...

Lymphoma - Symptoms and causes

Mayo Clinic - 23 May 2024
Lymphoma - Symptoms and causes ...

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

nejm.org - 24 Dec 2015
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma ...

A Case Report of a Female Patient With Hodgkin Lymphoma Localized in the Central Nervous System and With Concomitant Pulmonary Lymphomatoid Granulomatosis

Frontiers - 09 Feb 2024
A Case Report of a Female Patient With Hodgkin Lymphoma Localized in the Central Nervous System and With Concomitant Pulmonary Lymphomatoid Granulomatosis ...

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma

nejm.org - 23 Jun 2016
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma ...

Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies | Blood Cancer Journal

Nature.com - 09 Jul 2021
Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies | Blood Cancer Journal ...